New drug could beat virus threat in transplant patients
Disease control
Recruiting now
This study tests a new drug, brincidofovir, against the current treatment cidofovir for adenovirus infection in children and adults who have had a stem cell transplant. About 180 participants will receive one of the two drugs intravenously until the virus is cleared or up to 12 w…
Phase: PHASE3 • Sponsor: SymBio Pharmaceuticals • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC